Literature DB >> 8536636

Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat.

O Braissant1, F Foufelle, C Scotto, M Dauça, W Wahli.   

Abstract

Peroxisome proliferator-activated receptors (PPARs) are members of the nuclear hormone receptor superfamily that can be activated by various xenobiotics and natural fatty acids. These transcription factors primarily regulate genes involved in lipid metabolism and also play a role in adipocyte differentiation. We present the expression patterns of the PPAR subtypes in the adult rat, determined by in situ hybridization using specific probes for PPAR-alpha, -beta and -gamma, and by immunohistochemistry using a polyclonal antibody that recognizes the three rat PPAR subtypes. In numerous cell types from either ectodermal, mesodermal, or endodermal origin, PPARs are coexpressed, with relative levels varying between them from one cell type to the other. PPAR-alpha is highly expressed in hepatocytes, cardiomyocytes, enterocytes, and the proximal tubule cells of kidney. PPAR-beta is expressed ubiquitously and often at higher levels than PPAR-alpha and -gamma. PPAR-gamma is expressed predominantly in adipose tissue and the immune system. Our results suggest new potential directions to investigate the functions of the different PPAR subtypes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8536636     DOI: 10.1210/endo.137.1.8536636

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  561 in total

1.  Peroxisome proliferator-activated receptor-gamma ligands reduce neuronal inducible nitric oxide synthase expression and cell death in vivo.

Authors:  M T Heneka; T Klockgether; D L Feinstein
Journal:  J Neurosci       Date:  2000-09-15       Impact factor: 6.167

Review 2.  Fat cell metabolism: insulin, fatty acids, and renin.

Authors:  L A Cassis
Journal:  Curr Hypertens Rep       Date:  2000-04       Impact factor: 5.369

Review 3.  Treatment of insulin resistance with peroxisome proliferator-activated receptor gamma agonists.

Authors:  J M Olefsky
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

Review 4.  Peroxisome proliferator-activated receptors: lipid binding proteins controling gene expression.

Authors:  Marc van Bilsen; Ger J van der Vusse; Andries J Gilde; Martijn Lindhout; Karin A J M van der Lee
Journal:  Mol Cell Biochem       Date:  2002-10       Impact factor: 3.396

Review 5.  PPARgamma as a potential therapeutic target in pulmonary hypertension.

Authors:  Roy L Sutliff; Bum-Yong Kang; C Michael Hart
Journal:  Ther Adv Respir Dis       Date:  2010-06       Impact factor: 4.031

6.  Regulation of insulin secretion, glucokinase gene transcription and beta cell proliferation by adipocyte-derived Wnt signalling molecules.

Authors:  S Schinner; F Ulgen; C Papewalis; M Schott; A Woelk; A Vidal-Puig; W A Scherbaum
Journal:  Diabetologia       Date:  2007-11-10       Impact factor: 10.122

7.  Lipoprotein lipase deficiency is associated with elevated acylation stimulating protein plasma levels.

Authors:  Sabina Paglialunga; Pierre Julien; Youssef Tahiri; Francois Cadelis; Jean Bergeron; Daniel Gaudet; Katherine Cianflone
Journal:  J Lipid Res       Date:  2009-02-23       Impact factor: 5.922

8.  RXR activators molecular signalling: involvement of a PPAR alpha-dependent pathway in the liver and kidney, evidence for an alternative pathway in the heart.

Authors:  Laïla Ouamrane; Gilberte Larrieu; Béatrice Gauthier; Thierry Pineau
Journal:  Br J Pharmacol       Date:  2003-03       Impact factor: 8.739

9.  15-Deoxy-delta12,14-PGJ2: endogenous PPARgamma ligand or minor eicosanoid degradation product?

Authors:  William S Powell
Journal:  J Clin Invest       Date:  2003-09       Impact factor: 14.808

10.  Differentiation of trophoblast giant cells and their metabolic functions are dependent on peroxisome proliferator-activated receptor beta/delta.

Authors:  Karim Nadra; Silvia I Anghel; Elisabeth Joye; Nguan Soon Tan; Sharmila Basu-Modak; Didier Trono; Walter Wahli; Béatrice Desvergne
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.